Pular para conteúdo

Cirurgia vascular e cardiotorácica

Manejo e reversão da anticoagulação

Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. (abre nova janela)

Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, Crowther M.

Fonte‎: Thromb Haemost 2016;116(5):879-90.

Indexado‎: PubMed 27488143

DOI‎: 10.1160/TH16-04-0266

https://www.ncbi.nlm.nih.gov/pubmed/27488143 (abre nova janela)

Reversal of warfarin: case-based practice recommendations. (abre nova janela)

Garcia DA, Crowther MA.

Fonte‎: Circulation 2012;125(23):2944-7.

Indexado‎: PubMed 22689931

DOI‎: 10.1161/CIRCULATIONAHA.111.081489

https://www.ncbi.nlm.nih.gov/pubmed/22689931 (abre nova janela)

Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding? (abre nova janela)

Gielen CL, Bruggemans EF, Stijnen T, Eikenboom J, Tavilla G, Brand A, Klautz RJ.

Fonte‎: Eur J Cardiothorac Surg 2015;48(4):e64-70.

Indexado‎: PubMed 26248820

DOI‎: 10.1093/ejcts/ezv269

https://www.ncbi.nlm.nih.gov/pubmed/26248820 (abre nova janela)

Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? (abre nova janela)

Mahmood S, Bilal H, Zaman M, Tang A.

Fonte‎: Interact Cardiovasc Thorac Surg 2012;14(4):406-14.

Indexado‎: PubMed 22228288

DOI‎: 10.1093/icvts/ivr124

https://www.ncbi.nlm.nih.gov/pubmed/22228288 (abre nova janela)

Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. (abre nova janela)

Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, Darzi A, Athanasiou T.

Fonte‎: Eur J Cardiothorac Surg 2007;31(6):1058-69.

Indexado‎: PubMed 17306555

DOI‎: 10.1016/j.ejcts.2007.01.029

https://www.ncbi.nlm.nih.gov/pubmed/17306555 (abre nova janela)

Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. (abre nova janela)

Mirow N, Zittermann A, Koertke H, Maleszka A, Knobl H, Coskun T, Kleesiek K, Koerfer R.

Fonte‎: J Cardiovasc Surg (Torino) 2008;49(2):277-84.

Indexado‎: PubMed 18431350

https://www.ncbi.nlm.nih.gov/pubmed/18431350 (abre nova janela)

Idarucizumab for dabigatran reversal. (abre nova janela)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Fonte‎: N Engl J Med 2015;373(6):511-20.

Indexado‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (abre nova janela)

Idarucizumab for dabigatran reversal - full cohort analysis. (abre nova janela)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Fonte‎: N Engl J Med 2017;377(5):431-41.

Indexado‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (abre nova janela)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (abre nova janela)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Fonte‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Indexado‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (abre nova janela)

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. (abre nova janela)

Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN.

Fonte‎: Circulation 2013;128(11):1234-43.

Indexado‎: PubMed 23935011

DOI‎: 10.1161/CIRCULATIONAHA.113.002283

https://www.ncbi.nlm.nih.gov/pubmed/23935011 (abre nova janela)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (abre nova janela)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Fonte‎: JAMA Surg 2013;148(6):538-47.

Indexado‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (abre nova janela)

Andexanet alfa for the reversal of Factor Xa inhibitor activity. (abre nova janela)

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA.

Fonte‎: N Engl J Med 2015;373(25):2413-24.

Indexado‎: PubMed 26559317

DOI‎: 10.1056/NEJMoa1510991

https://www.ncbi.nlm.nih.gov/pubmed/26559317 (abre nova janela)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (abre nova janela)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Fonte‎: Blood 2012;119(9):2172-4.

Indexado‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (abre nova janela)

Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. (abre nova janela)

Øvrum E, Tangen G, Tølløfsrud S, Skeie B, Ringdal MA, Istad R, Øystese R.

Fonte‎: J Thorac Cardiovasc Surg 2011;141(5):1145-9.

Indexado‎: PubMed 20709334

DOI‎: 10.1016/j.jtcvs.2010.07.003

https://www.ncbi.nlm.nih.gov/pubmed/20709334 (abre nova janela)